Wide Ranks

ICUI

ICU Medical, Inc.

159.75

Top Statistics
Market Cap 3 B Forward PE 22.54 Revenue Growth 6.50 %
Current Ratio 2.29 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins -4.74 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 19.46 Enterprise / Revenue 2.24 Price To Sales Trailing12 Months 1.67
Profitability
Profit Margins -4.74 % Operating Margins 3.58 %
Balance Sheet
Total Cash 324 M Total Cash Per Share 13.27 Total Debt 1 B
Total Debt To Equity 81.03 Current Ratio 2.29 Book Value Per Share 83.76
All Measures
Short Ratio 259.00 % Message Board Id finmb_317440 Fax 949 366 8368
Shares Short Prior Month 703438 Return On Equity -0.0535 City San Clemente
Uuid e1b314ab-b805-333d-9287-34c2df797c6f Previous Close 157.75 First Trade Date Epoch Utc 702 M
Book Value 83.76 Beta 0.6650 Total Debt 1 B
Volume 236722 Price To Book 1.91 Last Split Date 1 B
Fifty Two Week Low 83.26 Total Cash Per Share 13.27 Total Revenue 2 B
Shares Short Previous Month Date 1 B Target Median Price 204.50 Audit Risk 4
Max Age 86400 Recommendation Mean 2.29 Sand P52 Week Change 0.3133
Operating Margins 3.58 % Target Mean Price 203.50 Net Income To Common -111007000
Short Percent Of Float 0.0378 Implied Shares Outstanding 24 M Trailing Peg Ratio 169.85 %
Last Fiscal Year End 1 B Average Daily Volume10 Day 269580 Average Volume10days 269580
Total Cash 324 M Next Fiscal Year End 1 B Revenue Per Share 96.30
Held Percent Insiders 0.0784 Ebitda Margins 11.52 % Trailing PE 0.0000
Date Short Interest 1 B Most Recent Quarter 1 B Share Holder Rights Risk 6
Regular Market Previous Close 157.75 Target Low Price 178.00 Gmt Off Set Milliseconds -18000000
Fifty Day Average 175.28 Open 158.54 Free Cashflow 280 M
State CA Dividend Yield 0.00 % Return On Assets 0.0066
Time Zone Short Name EST Board Risk 4 Trailing Eps -4.55
Day Low 156.21 Address1 951 Calle Amanecer Shares Outstanding 24 M
Compensation Risk 4 Price Hint 2 Target High Price 225.00
Website https://www.icumed.com 52 Week Change 0.8203 Average Volume 260970
Forward Eps 6.83 Recommendation Key buy Compensation As Of Epoch Date 1 B
Quick Ratio 91.40 % Last Split Factor 3:2 Regular Market Day High 161.28
Is_sp_500 False Profit Margins -4.74 % Debt To Equity 81.03
Fifty Two Week High 196.26 Day High 161.28 Shares Short 582421
Regular Market Open 158.54 Industry Key medical-instruments-supplies Earnings Growth 0.00 %
Enterprise To Revenue 2.24 Revenue Growth 6.50 % Shares Percent Shares Out 0.0238
Operating Cashflow 255 M Currency USD Time Zone Full Name America/New_York
Market Cap 3 B Is_nasdaq_100 False Zip 92673
Quote Type EQUITY Industry Medical Instruments & Supplies Long Name ICU Medical, Inc.
Overall Risk 4 Regular Market Day Low 156.21 Held Percent Institutions 1.01
Current Price 159.75 Enterprise To Ebitda 19.46 Financial Currency USD
Current Ratio 2.29 Gross Margins 32.87 % Industry Disp Medical Instruments & Supplies
Number Of Analyst Opinions 6 Country United States Float Shares 22 M
Two Hundred Day Average 133.23 Governance Epoch Date 1 B Ir Website http://ir.icumed.com/
Price To Sales Trailing12 Months 1.67 Enterprise Value 5 B Forward PE 22.54
Regular Market Volume 236722 Ebitda 269 M Exchange NMS
Go to Yahoo Finance Go to Seeking Alpha 
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide.

Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.

The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options.

It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services.

The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities.

ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.